Home Capital Broker's Calls

Venture still has much to gain amid healthy outlook

Stanislaus Jude Chan
Stanislaus Jude Chan6/6/2018 12:47 PM GMT+08  • 3 min read
Venture still has much to gain amid healthy outlook
SINGAPORE (June 6): Maybank Kim Eng Research is keeping its “buy” call on Venture Corp with an unchanged target price of $28.83 amid healthy revenue forecasts among its customers.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (June 6): Maybank Kim Eng Research is keeping its “buy” call on Venture Corp with an unchanged target price of $28.83 amid healthy revenue forecasts among its customers.

“We believe Venture remains a beneficiary of economic upcycle and multifaceted secular growth drivers,” says Lai Gene Lih in a report on Monday.

According to Lai, 10 out of Venture’s 16 well-known customers beat Street estimates in 1Q18, and 12 have raised or reaffirmed their guidance.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now